Skip to main content
. 2012 Jun 6;303(5):F621–F629. doi: 10.1152/ajprenal.00268.2012

Fig. 7.

Fig. 7.

Effect of chronic infusion of the arginine vasopressin analog [deamino-Cys1, d-Arg8]-vasopressin acetate hydrate (dDAVP) on AQP1 expression by rat TAL suspensions. A: representative Western blot of 2 different experiments. B: quantitative data showing the percent change in glycosylated (left) and nonglycosylated AQP1 (right) after dDAVP infusion (n = 4).